ask="N/A"
ask_size="N/A"
average_daily_volume="2566760"
bid="N/A"
bid_size="N/A"
book_value="0.072"
change="+0.018"
change_from_200_day_moving_average="0.121"
change_from_50_day_moving_average="0.100"
change_from_52_week_high="-0.053"
change_From_52_week_low="0.190"
change_in_percent="+5.843%"
close="0.317"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.043"
ebitda="-16.38M"
eps_estimate_current_year="-0.070"
eps_estimate_next_quarter="-0.030"
eps_estimate_next_year="-0.080"
ex_dividend_date="N/A"
float_shares="230204000"
high="0.335"
high_52_weeks="0.370"
last_trade_date="3/9/2017"
last_trade_price="0.317"
last_trade_size="3666"
last_trade_time="4:02pm"
low="0.293"
low_52_weeks="0.127"
market_capitalization="75.27M"
moving_average_200_day="0.196"
moving_average_50_day="0.217"
name="Rexahn Pharmaceuticals
Inc. Co"
notes="N/A"
one_year_target_price="2.500"
open="0.300"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="+61.962%"
percent_change_from_50_day_moving_average="+46.179%"
percent_change_from_52_week_high="-14.324%"
percent_change_from_52_week_low="+149.606%"
previous_close="0.299"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.160"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="237443000"
short_ratio="0.720"
stock_exchange="ASE"
symbol="RNN"
volume="12965921"
weeks_range_52="0.127 - 0.370"
